Technical Analysis for EMMA - Emmaus Life Sciences Inc

Grade Last Price % Change Price Change
grade F 1.47 -4.55% -0.0700
EMMA closed down 4.55 percent on Thursday, August 13, 2020, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical EMMA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction -4.55%
Wide Bands Range Expansion -4.55%
Older signals for EMMA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Emmaus Life Sciences, Inc. engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases in the United States and internationally. It provides Endari, which is L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older; NutreStore L-glutamine powder; and AminoPure, a nutritional supplement. The company also develops therapeutic products based on cell sheet technology for the treatment of corneal diseases. In addition, it focuses on developing pharmaceutical-grade L-glutamine oral powder for diverticulosis. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.
Medicine Health Medical Specialties Pharmaceutical Medication Therapeutic Products Therapeutic Cell Sheet Technology Corneal Diseases Diverticulosis Endari Glutamine Rare And Orphan Diseases Sickle Cell Disease Treatment Of Corneal Diseases

Is EMMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.85
52 Week Low 0.85
Average Volume 24,229
200-Day Moving Average 1.7749
50-Day Moving Average 1.7598
20-Day Moving Average 1.8123
10-Day Moving Average 1.6140
Average True Range 0.1856
ADX 17.22
+DI 19.8937
-DI 21.4192
Chandelier Exit (Long, 3 ATRs ) 1.6032
Chandelier Exit (Short, 3 ATRs ) 1.9568
Upper Bollinger Band 2.2537
Lower Bollinger Band 1.3709
Percent B (%b) 0.11
BandWidth 48.7116
MACD Line -0.0769
MACD Signal Line -0.0271
MACD Histogram -0.0499
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.5000
Resistance 3 (R3) 1.4967 1.4833 1.4950
Resistance 2 (R2) 1.4833 1.4757 1.4850 1.4933
Resistance 1 (R1) 1.4767 1.4710 1.4800 1.4800 1.4917
Pivot Point 1.4633 1.4633 1.4650 1.4650 1.4633
Support 1 (S1) 1.4567 1.4557 1.4600 1.4600 1.4483
Support 2 (S2) 1.4433 1.4510 1.4450 1.4467
Support 3 (S3) 1.4367 1.4433 1.4450
Support 4 (S4) 1.4400